You just read:

Astellas and Seattle Genetics Announce Updated Enfortumab Vedotin Phase 1 Data in Metastatic Urothelial Cancer at 2017 ASCO Annual Meeting

News provided by

Astellas

Jun 05, 2017, 10:45 ET